European Companies Search Engine

Quick Search Power Search
Tips & Tricks
Our help pages Using the Quick Search and Power Search Overview explain how to use our search engine.

optimed medizinische Instrumente GmbH, Ettlingen, Germany

Watch

If you put a company on your watch list, we'll notify you on your email address when there are new publications regarding this company.

This feature is only available to our premium service subscribers.

Learn more about the North Data Premium Service

Dossier

The dossier is a printable PDF file, summarizing information and publications for this company. The creation of dossiers is included in your subscription. After the creation of the dossier is completed, it will be sent to your email address .

Add to dossier (if available):

This feature is only available to our premium service subscribers.

Learn more about the North Data Premium Service

Name

optimed medizinische Instrumente GmbH

Register

Ut
District Court of Mannheim HRB 361913
Lei
391200QN9GTDSTSVOK59

Address

Ferdinand-Porsche-Str. 11, 76275 Ettlingen, Germany

Corporate purpose

The industrial production of medical instruments, in particular as a general contractor and the distribution of medical instruments.

Financials

Employees

Employees

For this company, Employees numbers are only available to our premium service subscribers.

Learn more about the North Data Premium Service

History

Legal Representatives

Marketing & Tech

Network

Loading network

Publications

9 Apr 2024
Wordmark: “Rheos“
8 Apr 2024
Wordmark: “Douro“
14 Jul 2023
No longer Managing Director: Jürgen Kiesel
4 Jul 2023
Annual report for the year ending 31/12/2021 · Balance sheet for 31/12/2021 · Earnings statement for 31/12/2021
28 Jun 2023
Managing Director: Guido Derjung, Stefan Gimber · No longer Officer (2)
Year 2023 in Dp
6 patent filings: Hand unit for feeding and releasing an implant …
20 Oct 2022
Patent: Stent
20 Oct 2022
Patent: Stent
1 Mar 2022
Annual report for the year ending 31/12/2020 · Balance sheet for 31/12/2020 · Earnings statement for 31/12/2020
1 May 2021
Wordmark: “Micro V8“
1 May 2021
Wordmark: “PLANIS“
1 May 2021
Wordmark: “Ulti V8“
13 Jan 2021
Annual report for the year ending 31/12/2019 · Balance sheet for 31/12/2019 · Earnings statement for 31/12/2019
19 Nov 2020
Patent: Stent
4 Nov 2020
Patent: Stent for Using in Bifurcations
Year 2020 in Dm
6 wordmarks: Arydo-Valve, Freeman, InverSafe, NYLOTRACK, Plywire, Tentos
30 Jun 2020
Wordmark: “Freeman“
19 Jun 2020
Utility patent: Face
8 Jun 2020
Wordmark: “Tentos“
6 May 2020
Patent: Stent
23 Apr 2020
No longer Managing Director: Matthias Theisen
8 Apr 2020
Annual report for the year ending 31/12/2018 · Balance sheet for 31/12/2018 · Earnings statement for 31/12/2018
1 Apr 2020 in Fk
Public funding (€651,803): Vascular valve for the treatment of newborns with hypoplastic left heart syndrome and left heart complex (Optimize) - Sub-projects: Research and development of an …
16 Mar 2020
Annual report for the year ending 31/12/2018 · Balance sheet for 31/12/2018 · Earnings statement for 31/12/2018
1 Feb 2020 in Fk
Public funding (€868,980): Bioabsorbable, drug-releasing zinc stent for minimally invasive treatment of coronary artery disease (BioZ-DES) - Subproject: Development of BioZ-DES Stent System
27 Dec 2019
Wordmark: “Freeman“
1 Oct 2019
Wordmark: “CibuFlex“
11 Sept 2019
Patent: Method for Producing a Stent
22 Aug 2019
Managing Director: Jürgen Kiesel
9 Jul 2019
No longer Officer (1)
24 Apr 2019
Patent: Stent
18 Mar 2019
Wordmark: “Impressor“
27 Feb 2019
Annual report for the year ending 31/12/2017 · Balance sheet for 31/12/2017 · Earnings statement for 31/12/2017
20 Feb 2019
Annual report for the year ending 30/06/2017 · Balance sheet for 30/06/2017 · Earnings statement for 30/06/2017
19 Dec 2018
Patent: Process for the production of a stent
3 Dec 2018
No longer Managing Director: Dirk J. Steindorf
Year 2018 in Dm
4 wordmarks: NanoFlex, NephroLen, OptiGlide, T-PEX
9 Nov 2018
No longer Managing Director: Nicholas Cooper
17 May 2018
Officer: Harald Fischer
20 Mar 2018
Managing Director: Dirk J. Steindorf, Matthias Theisen · Officer (2)
7 Mar 2018
Annual report for the year ending 31/12/2016 · Balance sheet for 31/12/2016 · Earnings statement for 31/12/2016
20 Dec 2017
No longer Officer (1)
2 Nov 2017
Share­holder agreement
12 Oct 2017
Original document: “Gesellschaftsvertrag / Satzung / Statut“
18 Sept 2017
Share­holder agreement
15 Sept 2017
Control: E-Med Solutions GmbH · Control: E-Med Solutions GmbH
14 Sept 2017
Patent: Stent for use on bifurcations
4 Sept 2017
Original document: “Unternehmensvertrag / Umwandlungsvertrag / sonstiger Vertrag“
1 Jun 2017
Share­holder agreement
3 May 2017
Original document: “Liste der Gesellschafter“
3 Mar 2017
Annual report for the year ending 31/12/2015 · Balance sheet for 31/12/2015 · Earnings statement for 31/12/2015
26 Jan 2017
Patent: Stent
5 Oct 2016
Patent: Stent
23 Mar 2016
Annual report for the year ending 31/12/2014 · Balance sheet for 31/12/2014 · Earnings statement for 31/12/2014
18 Mar 2016
Wordmark: “sinus-XLr8“
Year 2015 in Dm
5 wordmarks: OptiPur, Zelos, sinus-Obliquus, sinus-Venous, sinus-XL
7 Dec 2015
Officer (1)
13 Oct 2015
Patent: Stent for Percutaneous Vertebroplasty
4 Aug 2015 via optimed Medizinische Instrumente GmbH
Shareholding: optimed Medizinische Instrumente GmbH
18 Nov 2014
Annual report for the year ending 31/12/2013 · Balance sheet for 31/12/2013 · Earnings statement for 31/12/2013
10 Nov 2014
Word figurative mark
1 Jul 2014 in Fk
Public funding (€366,069): Bioabsorbable zinc-based vascular support for the treatment of peripheral stenosis (BioZStent) - Sub-projects: Functional model studies
19 Dec 2013
Share­holder agreement
1 Oct 2013
Wordmark: “sinus-Carotid“
29 Aug 2013
Annual report for the year ending 31/12/2012 · Balance sheet for 31/12/2012 · Earnings statement for 31/12/2012
16 Apr 2013
Wordmark: “OptiSplint“
17 Jan 2013
Utility patent: Dosing device for a physiologically acceptable gaseous medium
14 Nov 2012
Annual report for the year ending 31/12/2011 · Balance sheet for 31/12/2011 · Earnings statement for 31/12/2011
1 Jun 2012
No longer Officer (1)
10 Apr 2012
Officer (1)
2 Apr 2012
Officer (1)
20 Jan 2012
Wordmark: “OptiLayer“
30 Dec 2011
Managing Director: Nicholas Cooper · No longer Managing Director (1)
2 Sept 2011
Wordmark: “CarboSoft“
2 Sept 2011
Wordmark: “OptiSoft“
25 Jul 2011
Annual report for the year ending 31/12/2010 · Balance sheet for 31/12/2010 · Earnings statement for 31/12/2010
29 Dec 2010
Annual report for the year ending 31/12/2009 · Balance sheet for 31/12/2009 · Earnings statement for 31/12/2009
12 Mar 2010
Wordmark: “Silaro“
19 Feb 2010
Annual report for the year ending 31/12/2008 · Balance sheet for 31/12/2008 · Earnings statement for 31/12/2008
Year 2009 in Dm
7 wordmarks: Cavuplasty, Dilexx-18, GastroSoft, NephroLen, Opti-J, OptiGlide, T-PEX
3 Feb 2009
Annual report for the year ending 31/12/2007 · Balance sheet for 31/12/2007 · Earnings statement for 31/12/2007
7 Nov 2008
Wordmark: “sinus-535“
6 Mar 2008
Officer (1)
19 Feb 2008
Annual report for the year ending 31/12/2006 · Balance sheet for 31/12/2006 · Earnings statement for 31/12/2006
28 Nov 2006
Reg­is­tra­tion · Managing Director (1) · Officer (2) · Capital: €1,300,000 · Seat: Ettlingen, Germany · Legal form: GmbH · Name: optimed medizinische Instrumente GmbH · Corporate Purpose

The data on this page is generated by a fully automated algorithm. It may have errors, and is provided on an "as is" basis with no guarantees of completeness, accuracy, usefulness or timeliness.

Creative Commons License The visualizations for "optimed medizinische Instrumente GmbH, Ettlingen, Germany" are provided by North Data and may be reused under the terms of the Creative Commons CC-BY license.

Printing is only available to North Data premium service subscribers.
Close